Avondale Wealth Management’s Humana HUM Stock Holding History

Avondale Wealth Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17	Closed	-$7K	–	126
2022 Q1	$7K	Buy	+17	New	+$7.11K	0.01%	101

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avondale Wealth Management's HUM Position: Q2 2022 in Review

Avondale Wealth Management sold out of Humana (HUM) in Q2 2022, closing a stake of 17 shares — an estimated $7K sold.

Avondale Wealth Management first reported a position in HUM in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

Avondale Wealth Management reported no remaining Humana position as of Q2 2022 after selling out during the quarter.
Avondale Wealth Management sold 17 Humana shares in Q2 2022, an estimated $7K.
Avondale Wealth Management first reported a position in Humana in Q1 2022 and held it in 1 quarter.
Avondale Wealth Management's Humana position peaked at $7K in Q1 2022.
959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Avondale Wealth Management's 13F filing for Q2 2022, filed 11 Jul 2022.